These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34133038)

  • 21. Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy.
    Natsui H; Konishi T; Saiin K; Tamaki Y; Sato T; Takenaka S; Tada A; Mizuguchi Y; Kobayashi Y; Sato T; Kamada R; Kamiya K; Nagai T; Tanaka S; Anzai T
    Cardiol J; 2022; 29(2):362-363. PubMed ID: 35411933
    [No Abstract]   [Full Text] [Related]  

  • 22. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
    Eroğlu I; Çelik Eroğlu B; Uyaroğlu OA; Sain Güven G
    Anatol J Cardiol; 2020 Jul; 24(1):19-20. PubMed ID: 32628145
    [No Abstract]   [Full Text] [Related]  

  • 23. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.
    Hashemi SMA; Thijssen M; Hosseini SY; Tabarraei A; Pourkarim MR; Sarvari J
    Arch Virol; 2021 Aug; 166(8):2089-2108. PubMed ID: 33934196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of tachyphylaxis on statin treatment.
    Miserez AR; Keller U; Mirsaidi R
    Am J Cardiol; 2001 Oct; 88(8):936-7. PubMed ID: 11676971
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of statin treatment for familial hypercholesterolaemia on life assurance: results of consecutive surveys in 1990 and 2002.
    Neil HA; Hammond T; Mant D; Humphries SE
    BMJ; 2004 Feb; 328(7438):500-1. PubMed ID: 14988185
    [No Abstract]   [Full Text] [Related]  

  • 27. Statins as candidate therapeutic agents for coronavirus disease 2019 (COVID-19).
    Li SD; Zhang SY; Peng B
    Chin Med J (Engl); 2020 Nov; 134(4):407-409. PubMed ID: 33617183
    [No Abstract]   [Full Text] [Related]  

  • 28. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 29. Statin use in patients with diabetes amid COVID-19 pandemic.
    Kow CS; Ramachandram DS; Hasan SS
    Diabetes Metab; 2022 Jan; 48(1):101298. PubMed ID: 34710617
    [No Abstract]   [Full Text] [Related]  

  • 30. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 31. For the patient. Disparities in statin trials for children.
    Belay B; Racine AD; Belamarich PF
    Ethn Dis; 2009; 19(2):218. PubMed ID: 19537236
    [No Abstract]   [Full Text] [Related]  

  • 32. Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia: Consequences for Cardiovascular Risk.
    Braamskamp MJAM; Kastelein JJP; Kusters DM; Hutten BA; Wiegman A
    J Am Coll Cardiol; 2016 Feb; 67(4):455-456. PubMed ID: 26821635
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID19 associated mucormycosis: Is GRP78 a possible link?
    Gumashta J; Gumashta R
    J Infect Public Health; 2021 Oct; 14(10):1351-1357. PubMed ID: 34538732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygous familial hypercholesterolemia.
    Choh SA; Choh NA; Rasool A; Yousuf R; Qureshi U
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):573-5. PubMed ID: 19694206
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipid laden in the true sense.
    Lohiya RV; Phadke M; Lanjewar C; Kerkar P
    Eur Heart J; 2015 Jan; 36(1):49. PubMed ID: 25336218
    [No Abstract]   [Full Text] [Related]  

  • 36. The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review.
    Sarfraz Z; Sarfraz A; Jaiswal V; Poudel S; Bano S; Hanif M; Singh Shrestha P; Sarfraz M; Michel G; Cherrez-Ojeda I
    J Prim Care Community Health; 2022; 13():21501319221099476. PubMed ID: 35587142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.
    Ravindra K; Ahlawat A
    Int J Infect Dis; 2021 Nov; 112():278-280. PubMed ID: 34592439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India.
    Chavan RP; Ingole SM; Nazir HA; Desai WV; Kanchewad GS
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3201-3210. PubMed ID: 35122509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.